| 18.07 22:16 | MÄRKTE USA/Wall Street verlängert Talfahrt |
| 18.07 19:07 | MÄRKTE USA/Wall Street dreht wieder ins Minus |
| 18.07 16:07 | MÄRKTE USA/Kraftlose Erholung nach heftigen Verlusten |
| 18.07 15:32 | dpa-AFX: *ABBOTT LABORATORIES -3,9% TROTZ GEWINNZIEL-ERHÖHUNG |
| 18.07 14:41 | MÄRKTE USA/Zaghafte Erholung nach heftigen Verlusten erwartet |
| 18.07 13:52 | dpa-AFX: ROUNDUP: Abbott Laboratories Boosts FY24 Earnings Outlook |
| 18.07 13:37 | dpa-AFX: *ABBOTT NARROWS 2024 ORGANIC SALES GROWTH GUIDANCE RANGE, EXCL. COVID-19 TESTING-RELATED SALES, TO 9.5% TO 10.0% |
| 18.07 13:36 | dpa-AFX: *ABBOTT RAISES 2024 EPS GUIDANCE; NOW EXPECTS FY EPS $3.30 TO $3.40, ADJ. EPS OF $4.61 TO $4.71 |
| 18.07 13:36 | dpa-AFX: Abbott Laboratories Q2 Profit Decreases, But Beats Estimates |
| 18.07 13:35 | dpa-AFX: *ABBOTT PROJECTS Q3 EPS TO BE $0.85 TO $0.89 |
| 18.07 13:35 | dpa-AFX: *ABBOTT EXPECTS Q3 EPS TO BE $0.85 TO $0.89, ADJ EPS OF $1.18 TO $1.22 |
| 18.07 13:34 | dpa-AFX: *ABBOTT Q2 NET SALES $10.38 BLN VS $9.98 BLN PRIOR YEAR |
| 18.07 13:33 | dpa-AFX: *ABBOTT Q2 NET EARNINGS $1.30 BLN VS $1.38 BLN PRIOR YEAR |
| 18.07 13:32 | dpa-AFX: *ABBOTT Q2 EPS $0.74 VS $0.78 PRIOR YEAR |
| 18.07 13:32 | dpa-AFX: *ABBOTT Q2 EPS, EXCL. ITEMS., RISES TO $1.14 FROM $1.08 PRIOR YEAR |
| 18.07 13:32 | dpa-AFX: *ABBOTT LABORATORIES VORBÖRSLICH +2% - WIRD BEI GEWINNZIEL ETWAS OPTIMISTISCHER |
| 18.07 12:04 | dpa-AFX: Abbott Laboratories Q2 24 Earnings Conference Call At 9:00 AM ET |
| 20.06 14:13 | dpa-AFX: *ABBOTT COLLABORATES WITH NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS TO ENHANCE NUTRITIONAL ACCESS &HEALTH OUTCOME |
| 14.06 19:48 | dpa-AFX: *ABBOTT DECLARES QUARTERLY DIVIDEND OF $0.55/SHARE, PAYABLE AUG. 15/ RECORD JULY 15 |
| 14.06 19:35 | dpa-AFX: *ABBOTT LABORATORIES (ABT) DECLARES QUARTERLY DIVIDEND OF $ 0.55, RECORD DATE 7/15/2024 |
|
|
